Search Results

You are looking at 31 - 38 of 38 items for :

  • "sub-Saharan Africa" x
  • Refine by Access: All x
Clear All
Full access

NCCN News

NCCN’s ongoing work in Sub-Saharan Africa with the African Cancer Coalition, American Cancer Society, Clinton Health Access Initiative, and IBM. Free recommendations for self-care and stress management for cancer patients, caregivers, and providers

Full access

NCCN News

management of pediatric Burkitt lymphoma and diffuse large B-cell lymphoma, and to illustrate how management differs from how these diseases are handled in adult patients.” Up next, NCCN plans to adapt these guidelines into NCCN Harmonized Guidelines for Sub-Saharan

Full access

NCCN News

Sub-Saharan Africa. Since joining NCCN full time, she has provided organizational guidance, spearheaded pilot programs for the Health Equity Report Card, has overseen oncology research grant facilitation through the NCCN Oncology Research Program

Full access

Evolving Paradigms in HIV Malignancies: Review of Ongoing Clinical Trials

Rachel A. Bender Ignacio, Lilie L. Lin, Lakshmi Rajdev, and Elizabeth Chiao

inhibitors, respectively). In addition, the burden of cancer is now being seen in sub-Saharan Africa (SSA) and other resource-limited regions, where longer life expectancy on ART and higher burden of viral oncogens has caused HIVAMs to become the second

Full access

Methylene Blue for the Treatment of Intractable Pain From Oral Mucositis Related to Cancer Treatment: An Uncontrolled Cohort

Carlos J. Roldan, Matthew Chung, Lei Feng, and Eduardo Bruera

treatment of malaria in sub-Saharan Africa 21 and for the treatment of ifosfamide-induced encephalopathy. 29 For diagnostic purposes, MB is used for tissue staining to help detect various gastrointestinal pathologies. 30 – 32 Similarly, intra

Full access

Wilms Tumor (Nephroblastoma), Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Frank Balis, Daniel M. Green, Clarke Anderson, Shelly Cook, Jasreman Dhillon, Kenneth Gow, Susan Hiniker, Rama Jasty-Rao, Chi Lin, Harold Lovvorn III, Iain MacEwan, Julian Martinez-Agosto, Elizabeth Mullen, Erin S. Murphy, Mark Ranalli, Daniel Rhee, Denise Rokitka, Elisabeth (Lisa) Tracy, Tamara Vern-Gross, Michael F. Walsh, Amy Walz, Jonathan Wickiser, Matthew Zapala, Ryan A. Berardi, and Miranda Hughes

– 51 . 8271283 10.1093/jnci/86.1.49 5. Apple A , Lovvorn HN III . Wilms tumor in Sub-Saharan Africa: molecular and social determinants of a global pediatric health disparity . Front Oncol 2020 ; 10 : 606380 . 10.3389/fonc.2020

Full access

Cancer in People Living With HIV, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology

Erin Reid, Gita Suneja, Richard F. Ambinder, Kevin Ard, Robert Baiocchi, Stefan K. Barta, Evie Carchman, Adam Cohen, Neel Gupta, Kimberly L. Johung, Ann Klopp, Ann S. LaCasce, Chi Lin, Oxana V. Makarova-Rusher, Amitkumar Mehta, Manoj P. Menon, David Morgan, Nitya Nathwani, Ariela Noy, Frank Palella, Lee Ratner, Stacey Rizza, Michelle A. Rudek, Jeff Taylor, Benjamin Tomlinson, Chia-Ching J. Wang, Mary A. Dwyer, and Deborah A. Freedman-Cass

highly active antiretroviral therapy and the presence of HPV, premalignant and malignant cervical lesions in sub-Saharan Africa, a systematic review: current evidence and directions for future research . BMJ Open 2017 ; 7 : e015123 . 218

Full access

Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

Jaffer A. Ajani, Thomas A. D’Amico, David J. Bentrem, Joseph Chao, David Cooke, Carlos Corvera, Prajnan Das, Peter C. Enzinger, Thomas Enzler, Paul Fanta, Farhood Farjah, Hans Gerdes, Michael K. Gibson, Steven Hochwald, Wayne L. Hofstetter, David H. Ilson, Rajesh N. Keswani, Sunnie Kim, Lawrence R. Kleinberg, Samuel J. Klempner, Jill Lacy, Quan P. Ly, Kristina A. Matkowskyj, Michael McNamara, Mary F. Mulcahy, Darryl Outlaw, Haeseong Park, Kyle A. Perry, Jose Pimiento, George A. Poultsides, Scott Reznik, Robert E. Roses, Vivian E. Strong, Stacey Su, Hanlin L. Wang, Georgia Wiesner, Christopher G. Willett, Danny Yakoub, Harry Yoon, Nicole McMillian, and Lenora A. Pluchino

one of the least commonly diagnosed cancers in Western Europe, sub-Saharan Africa, Australia, and North America. 6 In the United States, an estimated 26,560 people were to be diagnosed and 11,180 people were expected to die of this disease in 2021